Report cover image

Pharma Industry Mergers and Acquisitions Deals by Top Themes in 2022 - Thematic Intelligence

Publisher GlobalData
Published Feb 13, 2023
Length 22 Pages
SKU # GBDT17791180

Description

Pharma Industry Mergers and Acquisitions Deals by Top Themes in 2022 - Thematic Intelligence

Summary

This report analyzes the disruptive themes that have driven M&A activity in 2022 in the Pharma Sector

The pharma sector saw 784 M&A deals valued at $126 billion in 2022, a drop of 44% from 2021 in terms of deal value. The M&A activity dropped in most regions in 2022 compared to the previous year. North America continued to lead, with 385 deals worth $75 billion in 2022.

Scope
  • This report provides an overview of merger and acquisition activity globally in 2022 in Pharma Sector
  • It identifies the themes driving most notable to deals announced in 2022 in the Pharma Sector
Reasons to Buy
  • Companies who invest in the right themes become success stories; those who miss the big themes end up as failures. If you want to understand the themes that drive an industry, simply look at the list of recent mergers and acquisitions (M&A).
  • In this report we have listed down the most notable deals in pharma sector to make it easy for our clients to get a view of themes disrupting the sector and prepare for the future.

Table of Contents

22 Pages
Executive Summary
Review of the pharma M&A deals in 2022
Themes driving the pharma M&A deals in 2022
Appendix 1: Deal selection criteria
Appendix 2: Our thematic research methodology
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.